Abstract
BMS-470539, a recently introduced selective agonist of the melanocortin 1 receptor, is known to have anti-inflammatory properties. In this study, we investigated the effects of BMS-470539 on lipopolysaccharide (LPS)-induced inflammatory responses and delayed apoptosis with its signaling pathways in human neutrophils. Isolated human neutrophils were incubated with various concentrations of BMS-470539 (1, 10, and 100 µM) in the presence or absence of LPS (100 ng/ml), and the expression of pro-inflammatory cytokines, such as tumor necrosis factor alpha, interleukin (IL)-6, and IL-1β, were assessed. The effects of BMS-470539 on the expression of mitogen-activated protein kinases (MAPKs), such as p38, extracellular-signal-regulated kinase 1/2, and c-Jun N-terminal kinase, and the expression of nuclear factor kappa B (NF-κB) in LPS-stimulated human neutrophils, were evaluated by enzyme-linked immunosorbent assay. Neutrophil apoptosis was also measured by fluorescence-activated cell sorting (annexin V/propidium iodide) in LPS-stimulated neutrophils under treatment with BMS-470539. BMS-470539 attenuated LPS-induced expression of pro-inflammatory cytokines, and phosphorylation of MAPKs and NF-κB. LPS stimulation reduced neutrophil apopt...Continue Reading
References
Jul 4, 2002·International Immunology·Shuji NaganoMine Harada
Mar 21, 2003·Journal of Medicinal Chemistry·Timothy F HerpinJohn E Macor
Mar 7, 2006·European Journal of Pharmacology·Rita SelvaticiSusanna Spisani
Aug 5, 2006·Journal of Leukocyte Biology·Liya KangKenneth E Carlson
Oct 26, 2006·Journal of Leukocyte Biology·Alexandre CloutierPatrick P McDonald
Mar 25, 2010·British Journal of Pharmacology·G LeoniM Perretti
Sep 21, 2010·TheScientificWorldJournal·Anna CataniaStefano Gatti
Apr 1, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katsunari KinaKazuhisa Iwabuchi
Jan 1, 2011·Frontiers in Immunology·Hetal B PatelMauro Perretti
Sep 7, 2012·PloS One·Yi ZongDi Lu
Jun 6, 2013·International Journal of Inflammation·Tazeen J AhmedCostantino Pitzalis
Feb 6, 2014·PloS One·Annika Lindskog JonssonJenny Nyström
Jun 22, 2015·BMC Musculoskeletal Disorders·Franco CapsoniAnna Catania
Jun 27, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Paul M HollowayFelicity N E Gavins
Jan 20, 2017·PloS One·Judit VáradiMiklós Vecsernyés
Apr 30, 2017·Circulation·Petteri RinneSabine Steffens
Nov 22, 2017·Signal Transduction and Targeted Therapy·Ting LiuShao-Cong Sun
Feb 23, 2018·Oncotarget·Linlin ChenLing Zhao
Aug 30, 2018·Frontiers in Pharmacology·Sara PatrunoTrinidad Montero-Melendez